Counting alleles to predict recurrence of early-stage colorectal cancers

Lancet

Volumn 359, Issue 9302, 2002, Pages 219-225

  Zhou, Wei ^b,d   Goodman, Steven N ^b   Galizia, Gennaro ^e   Lieto, Eva ^e   Ferraraccio, Francesca ^e   Pignatelli, Carlo ^e   Purdie, Colin A ^f   Piris, Juan ^f   Morris, Robert ^f   Harrison, David J ^f   Paty, Philip B ^g   Culliford, Al ^g   Romans, Katharine E ^b   Montgomery, Elizabeth A ^c   Choti, Michael A ^c   Kinzler, Kenneth W ^b   Vogelstein, Bert ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 18Q; CHROMOSOME 8P; CHROMOSOME ABERRATION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GENE FREQUENCY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; TECHNIQUE; TUMOR;

EID: 0037132902     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)07448-2     Document Type: Article

References (30)

1. The role of multiploidy as unfavorable prognostic variable in colorectal cancer
2. Redefining the significance of aneuploidy in the prognostic assessment of colorectal cancer
3. Lessons from hereditary colorectal cancer
4. Loss of heterozygosity at 3p23 is correlated with poor survival in patients with colorectal carcinoma
5. Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma
6. Genomic alterations (LOH, MI) on chromosome 17q21-23 and prognosis of sporadic colorectal cancer
7. Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: Two mutational patterns and a locus associated with poorer survival
8. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer
9. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator
10. Allelic loss of chromosome 18q and prognosis in colorectal cancer
11. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers
12. Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer
13. Allelic loss of chromosome 2p21-16.3 is associated with reduced survival in sporadic colorectal cancer
14. Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer
15. Molecular predictors of survival after adjuvant chemotherapy for colon cancer
16. Chromosome 8 losses in colorectal carcinoma: Localization and correlation with invasive disease
17. 2000 Update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology
18. Loss of heterozygosity in tumor cells requires re-evaluation: The data are biased by the size-dependent differential sensitivity of allele detection
19. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis
20. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma
21. Counting alleles reveals a connection between chromosome 18q loss and vascular invasion
22. Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC)
23. Mechanisms underlying losses of heterozygosity in human colorectal cancers
24. Mad-related genes in the human
25. Microsatellite instability in cancer of the proximal colon
26. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer
27. Standardized approach for microsatellite instability detection in colorectal carcinomas
28. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer
29. Clues to the pathogenesis of familial colorectal cancer
30. Flow cytometric DNA analysis of human solid tumors: A review of the interpretation of DNA histograms